Were seeing more people ask about GLP-1 medications like Wegovy, even those who dont meet the official weight criteria
GLP-1 is the target of many synthetic drugs on the market, initially developed in the treatment of type II diabetes, including: Exendin-4 (ELISA Product S-1297 , Rabbit anti-Exendin-4 Product T-4844 ): In the brain, it increases survival of dopamine neurons and decreases apoptosis of nerve cells, improving neuroplasticity
The consensus statement does suggest, however, that DPP-4 inhibitors may be appropriate in select populations based on concerns associated with weight gain and hypoglycemia, similar to the AACE and ACE recommendations
/ If you need naproxen, use the smallest effective dose for the shortest time possible
197 , kiae633 (2024)
Chakrabarti, S., Jadon, D